[Icosapent ethyl (cardiovascular risk reduction) - Addendum to Commission A21-113]

Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen
Record ID 32018004042
Original Title: Icosapent-Ethyl (Reduzierung des kardiovaskulaeren Risikos)
Project Status: Completed
Year Published: 2022
English language abstract: There is no English language summary available
Publication Type: Full HTA
Country: Germany
MeSH Terms
  • Cardiovascular Diseases
  • Heart Disease Risk Factors
  • Hypertriglyceridemia
  • Fatty Acids, Omega-3
  • Cholesterol
  • Eicosapentaenoic Acid
  • Risk Factors
  • Eicosapentaenoic Acid Ethyl Ester
  • Heart Disease Risk Factors
  • Hypertriglyceridemia
  • Benefit Assessment
  • NCT01492361
Organisation Name: Institute for Quality and Efficiency in Health Care (IQWiG)
Contact Address: IQWiG, Im Mediapark, 8, DE-50670 Cologne, GERMANY, Tel: +49(0)221-35685, Fax: +49(0)221-356851
Contact Email: berichte@iqwig.de
Copyright: Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.